Research priorities for elimination of visceral leishmaniasis

The Lancet Global Health

Volumn 2, Issue 12, 2014, Pages e683-e684

  Matlashewski, Greg ^a   Arana, Byron ^b   Kroeger, Axel ^b   Be Nazir, Ahmed ^c   Mondal, Dinesh ^d   Nabi, Shan Golam ^c   Banjara, Megha Raj ^e   Das, Murari Lal ^f   Marasini, Baburam ^g   Das, Pradeep ^h   Medley, Graham ⁱ   Satoskar, Abhay ^j   Nakhasi, Hira ^k   Argaw, Daniel ^l   Reeder, John ^b   Olliaro, Piero ^b  

^a MCGILL UNIVERSITY   (Canada)

^b Communicable Disease Control ^*  (Switzerland)

^c Icddr B   (Bangladesh)

^d INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^e TRIBHUVAN UNIVERSITY   (Nepal)

^f B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

^g Epidemiology and Disease Control Division   (Nepal)

^h RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

ⁱ UNIVERSITY OF WARWICK   (United Kingdom)

^j OHIO STATE UNIVERSITY   (United States)

^k CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^l WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEISHMANIA VACCINE; BIOLOGICAL MARKER; PROTOZOAL VACCINE;

DISEASE ELIMINATION; DISEASE TRANSMISSION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; IMMUNE RESPONSE; IMMUNITY; MEDICATION COMPLIANCE; NOTE; PARASITE LOAD; POINT OF CARE TESTING; PSYCHODIDAE; RESEARCH PRIORITY; SKIN LEISHMANIASIS; SURVIVAL; VECTOR CONTROL; VISCERAL LEISHMANIASIS; XENODIAGNOSIS; HEALTH; HUMAN; LEISHMANIASIS, VISCERAL; ORGANIZATION AND MANAGEMENT; RESEARCH; TRANSMISSION;

BIOLOGICAL MARKERS; GLOBAL HEALTH; HEALTH POLICY; HUMANS; LEISHMANIASIS, VISCERAL; PROTOZOAN VACCINES; RESEARCH;

EID: 84918822579     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(14)70318-3     Document Type: Note

References (1)

1. Control of the leishmaniases 2010, WHO, World Health Organization, Geneva.